MARKET

AUPH

AUPH

Aurinia Pharmace
NASDAQ
15.31
+0.40
+2.68%
Pre Market: 15.36 +0.05 +0.33% 07:00 12/05 EST
OPEN
14.76
PREV CLOSE
14.91
HIGH
15.35
LOW
14.76
VOLUME
12
TURNOVER
0
52 WEEK HIGH
16.48
52 WEEK LOW
6.55
MARKET CAP
2.02B
P/E (TTM)
27.30
1D
5D
1M
3M
1Y
5Y
1D
Top SA Quant rated small-cap stocks as Russell 2000 notches a record close
Seeking Alpha · 16h ago
Aurinia Pharmaceuticals Cut to Market Perform From Outperform by Leerink Partners
Dow Jones · 2d ago
Aurinia Pharmaceuticals Price Target Raised to $16.00/Share From $15.00 by Leerink Partners
Dow Jones · 2d ago
Leerink Partners Downgrades Aurinia Pharmaceuticals to Market Perform, Raises Price Target to $16
Benzinga · 2d ago
AURINIA PHARMACEUTICALS INC <AUPH.O>: LEERINK PARTNERS CUTS TO MARKET PERFORM FROM OUTPERFORM; RAISES TARGET PRICE TO $16 FROM $15
Reuters · 2d ago
Aurinia Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
TipRanks · 2d ago
Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options
NASDAQ · 2d ago
Weekly Report: what happened at AUPH last week (1124-1128)?
Weekly Report · 4d ago
More
About AUPH
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. It has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis (LN) and continues to conduct clinical and regulatory activities to support the LUPKYNIS development program. The Company is also developing aritinercept (AUR200), a dual inhibitor of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) for the potential treatment of autoimmune diseases. It sells LUPKYNIS to specialty pharmacies and a specialty distributor in the United States and sells LUPKYNIS inventory to its collaboration partner, Otsuka Pharmaceutical Co., Ltd. (Otsuka), for the European and Japanese market. The Company sells encapsulated voclosporin to its collaboration partner, Otsuka, which Otsuka then sells to customers in its territories.

Webull offers Aurinia Pharmaceuticals Inc stock information, including NASDAQ: AUPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AUPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AUPH stock methods without spending real money on the virtual paper trading platform.